CNS Update: Effects of dose titration on adherence and treatment duration of pregabalin among patients with neuropathic pain: A MarketScan database study |
News and Updates
eMediNexus Coverage from: 
CNS Update: Effects of dose titration on adherence and treatment duration of pregabalin among patients with neuropathic pain: A MarketScan database study
eMediNexuS,  28 May 2022
Coronavirus Live Count Map India

remove_red_eye 1189 Views
COVID-19 Vaccine Updates


#Neurology

0 Read Comments                

A study examined the dose titration of pregabalin and the impact on treatment adherence and duration in patients with neuropathic pain (NeP).

The study utilized MarketScan database (2009–2014) to extract a cohort of adult pregabalin users with NeP – with at least 12 months of follow-up data.

Overall, 5,186 patients were analyzed; 18% of patients had dose titrations. Patients with dose titration were 2.6 times more likely to be treatment adherent compared to those who did not have dose titration. In addition, the time to discontinuation or switch was considerably longer among patients with dose titration.

Hence, the results disclosed that pregabalin dose titration was associated with greater treatment persistence and adherence among NeP patients. These data is likely to improve physician awareness regarding dose recommendations.  

To comment on this article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now